RUA Life Sciences is a newly-formed medical device business created by the acquisition of RUA Medical Devices Ltd by AorTech International plc in April 2020. As a holding company, RUA Life Sciences operates four businesses with the aim of improving the lives of patients through the use of their polymer technology, specifically Elast-EonTM. This technology is the world's leading long-term implantable polyurethane, making it a valuable asset in enhancing and enabling medical devices.
Rua Life Sciences's ticker is RUA
The company's shares trade on the LSE stock exchange
They are based in Glasgow, Scotland
There are 11-50 employees working at Rua Life Sciences
It is https://rualifesciences.com/
Rua Life Sciences is in the Healthcare sector